Market closedNon-fractional
Vor Biopharma/VOR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Vor Biopharma
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
Ticker
VOR
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Cambridge, United States
Employees
168
Website
www.vorbio.com
Vor Biopharma Metrics
BasicAdvanced
$62M
Market cap
-
P/E ratio
-$1.78
EPS
-0.24
Beta
-
Dividend rate
Price and volume
Market cap
$62M
Beta
-0.24
Financial strength
Current ratio
8.463
Quick ratio
8.134
Long term debt to equity
25.019
Total debt to equity
28.235
Management effectiveness
Return on assets (TTM)
-35.97%
Return on equity (TTM)
-68.07%
Valuation
Price to book
0.51
Price to tangible book (TTM)
0.51
Price to free cash flow (TTM)
-0.571
Growth
Earnings per share change (TTM)
-14.93%
3-year earnings per share growth
-43.18%
What the Analysts think about Vor Biopharma
Analyst Ratings
Majority rating from 9 analysts.
Vor Biopharma Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$31M
17.56%
Profit margin
0.00%
NaN%
Vor Biopharma Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.45
-$0.49
-$0.39
-$0.45
-
Expected
-$0.43
-$0.47
-$0.50
-$0.38
-$0.42
Surprise
4.09%
4.58%
-22.52%
18.87%
-
Vor Biopharma News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Vor Biopharma stock?
Vor Biopharma (VOR) has a market cap of $62M as of July 06, 2024.
What is the P/E ratio for Vor Biopharma stock?
The price to earnings (P/E) ratio for Vor Biopharma (VOR) stock is 0 as of July 06, 2024.
Does Vor Biopharma stock pay dividends?
No, Vor Biopharma (VOR) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Vor Biopharma dividend payment date?
Vor Biopharma (VOR) stock does not pay dividends to its shareholders.
What is the beta indicator for Vor Biopharma?
Vor Biopharma (VOR) has a beta rating of -0.24. This means that it has an inverse relation to market volatility.
Buy or sell Vor Biopharma stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.